SOW
MRNS

State of Wyoming’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

State of Wyoming’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,688
Closed -$1.98K – 1948
2024
Q2 		$1.98K Buy
+1,688
New +$4.22K ﹤0.01% 1614
2022
Q2 		– Sell
-611
Closed -$6K – 2205
2022
Q1 		$6K Buy
611
+6
+1% +$60 ﹤0.01% 1652
2021
Q4 		$7K Sell
605
-5
-0.8% -$58 ﹤0.01% 1701
2021
Q3 		$7K Buy
610
+526
+626% +$7.23K ﹤0.01% 1069
2021
Q2 		$2K Buy
+84
New +$1.35K ﹤0.01% 1124

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

State of Wyoming's MRNS Position: Q3 2024 in Review

State of Wyoming sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 1,688 shares — an estimated $1.98K sold.

State of Wyoming first reported a position in MRNS in Q2 2021 and held it in 5 quarters. The position peaked at $7K in Q4 2021. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

  • State of Wyoming reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
  • State of Wyoming sold 1,688 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $1.98K.
  • State of Wyoming first reported a position in Marinus Pharmaceuticals, Inc in Q2 2021 and held it in 5 quarters.
  • State of Wyoming's Marinus Pharmaceuticals, Inc position peaked at $7K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on State of Wyoming's 13F filing for Q3 2024, filed 14 Nov 2024.